Jenne Kyle bought IONS
March 10, 2026 · Form 4 insider transaction
Jenne Kyle bought 4,675 shares of Ionis Pharmaceuticals, Inc. at $34.69 per share, a transaction worth $162.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,675
Price
$34.69
Total value
$162.2K
InsiderJenne Kyle
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 10, 2026
Filing dateMarch 11, 2026
Shares owned after16,389
OwnershipDirect
10b5-1 planNo
AmendedNo